Optimizing Patient Risk Stratification for Colonoscopy Screening and Surveillance of Colorectal Cancer: The Role for Linked Data

Overview

Journal Front Public Health

Specialty Public Health

Date 2017 Sep 26

PMID 28944221

Citations 2

Authors

David B Preen

Iris Lansdorp-Vogelaar

Hooi C Ee

Cameron Platell

Dayna R Cenin

Lakkhina Troeung

Max Bulsara

Peter OLeary

Affiliations

Soon will be listed here.

Citing Articles

FIT for purpose: study protocol for a randomized controlled trial to personalize surveillance colonoscopy for individuals at elevated risk of colorectal cancer.

Winter J, Cornthwaite K, Young G, Wilson C, Chen G, Woodman R Int J Colorectal Dis. 2023; 38(1):201.

PMID: 37490150 PMC: 10368549. DOI: 10.1007/s00384-023-04493-8.

Delineating colorectal cancer distribution, interaction, and risk prediction by environmental risk factors and serum trace elements.

Mohammed Nawi A, Chin S, Mazlan L, Jamal R Sci Rep. 2020; 10(1):18670.

PMID: 33122698 PMC: 7596468. DOI: 10.1038/s41598-020-75760-9.

References

Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M . Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2014; 136(5):E359-86. DOI: 10.1002/ijc.29210. View

Win A, MacInnis R, Hopper J, Jenkins M . Risk prediction models for colorectal cancer: a review. Cancer Epidemiol Biomarkers Prev. 2011; 21(3):398-410. DOI: 10.1158/1055-9965.EPI-11-0771. View

Robertson D, Burke C, Welch H, Haile R, Sandler R, Greenberg E . Using the results of a baseline and a surveillance colonoscopy to predict recurrent adenomas with high-risk characteristics. Ann Intern Med. 2009; 151(2):103-9. PMC: 2779048. DOI: 10.7326/0003-4819-151-2-200907210-00007. View

Dear R, Barratt A, Evans A, Simes J, Newsom J, Kent D . Identifying and prioritising gaps in colorectal cancer trials research in Australia. Med J Aust. 2012; 197(9):507-11. DOI: 10.5694/mja12.10623. View

Cenin D, OLeary P, Lansdorp-Vogelaar I, Preen D, Jenkins M, Moses E . Integrating personalised genomics into risk stratification models of population screening for colorectal cancer. Aust N Z J Public Health. 2016; 41(1):3-4. DOI: 10.1111/1753-6405.12587. View

Klabunde C, Cronin K, Breen N, Waldron W, Ambs A, Nadel M . Trends in colorectal cancer test use among vulnerable populations in the United States. Cancer Epidemiol Biomarkers Prev. 2011; 20(8):1611-21. PMC: 3153583. DOI: 10.1158/1055-9965.EPI-11-0220. View

Bian J, Bennett C, Cooper G, DAlfonso A, Fisher D, Lipscomb J . Assessing Colorectal Cancer Screening Adherence of Medicare Fee-for-Service Beneficiaries Age 76 to 95 Years. J Oncol Pract. 2016; 12(6):e670-80. PMC: 5946705. DOI: 10.1200/JOP.2015.009118. View

van Heijningen E, Lansdorp-Vogelaar I, Kuipers E, Dekker E, Lesterhuis W, Borg F . Features of adenoma and colonoscopy associated with recurrent colorectal neoplasia based on a large community-based study. Gastroenterology. 2013; 144(7):1410-8. DOI: 10.1053/j.gastro.2013.03.002. View

Cairns S, Scholefield J, Steele R, Dunlop M, Thomas H, Evans G . Guidelines for colorectal cancer screening and surveillance in moderate and high risk groups (update from 2002). Gut. 2010; 59(5):666-89. DOI: 10.1136/gut.2009.179804. View

10.

Smith G, ODwyer P . Sensitivity of double contrast barium enema and colonoscopy for the detection of colorectal neoplasms. Surg Endosc. 2001; 15(7):649-52. DOI: 10.1007/s004640000372. View

11.

Ladabaum U, Song K . Projected national impact of colorectal cancer screening on clinical and economic outcomes and health services demand. Gastroenterology. 2005; 129(4):1151-62. DOI: 10.1053/j.gastro.2005.07.059. View

12.

Lansdorp-Vogelaar I, M Kuntz K, Knudsen A, van Ballegooijen M, Zauber A, Jemal A . Contribution of screening and survival differences to racial disparities in colorectal cancer rates. Cancer Epidemiol Biomarkers Prev. 2012; 21(5):728-36. PMC: 3531983. DOI: 10.1158/1055-9965.EPI-12-0023. View

13.

Boyle P, Ferlay J . Mortality and survival in breast and colorectal cancer. Nat Clin Pract Oncol. 2005; 2(9):424-5. DOI: 10.1038/ncponc0288. View

14.

Lieberman D, Rex D, Winawer S, Giardiello F, Johnson D, Levin T . Guidelines for colonoscopy surveillance after screening and polypectomy: a consensus update by the US Multi-Society Task Force on Colorectal Cancer. Gastroenterology. 2012; 143(3):844-857. DOI: 10.1053/j.gastro.2012.06.001. View

15.

Boyle P, Langman J . ABC of colorectal cancer: Epidemiology. BMJ. 2000; 321(7264):805-8. PMC: 1118620. DOI: 10.1136/bmj.321.7264.805. View

16.

Winawer S, Fletcher R, Miller L, Godlee F, Stolar M, Mulrow C . Colorectal cancer screening: clinical guidelines and rationale. Gastroenterology. 1997; 112(2):594-642. DOI: 10.1053/gast.1997.v112.agast970594. View

17.

Johnson M, Grubber J, Grambow S, Maciejewski M, Dunn-Thomas T, Provenzale D . Physician Non-adherence to Colonoscopy Interval Guidelines in the Veterans Affairs Healthcare System. Gastroenterology. 2015; 149(4):938-51. DOI: 10.1053/j.gastro.2015.06.026. View

18.

Siegel R, Jemal A, Ward E . Increase in incidence of colorectal cancer among young men and women in the United States. Cancer Epidemiol Biomarkers Prev. 2009; 18(6):1695-8. DOI: 10.1158/1055-9965.EPI-09-0186. View

19.

Martinez M, Baron J, Lieberman D, Schatzkin A, Lanza E, Winawer S . A pooled analysis of advanced colorectal neoplasia diagnoses after colonoscopic polypectomy. Gastroenterology. 2009; 136(3):832-41. PMC: 3685417. DOI: 10.1053/j.gastro.2008.12.007. View

20.

Pinsky P, Schoen R, Weissfeld J, Church T, Yokochi L, Doria-Rose V . The yield of surveillance colonoscopy by adenoma history and time to examination. Clin Gastroenterol Hepatol. 2008; 7(1):86-92. DOI: 10.1016/j.cgh.2008.07.014. View